Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

UNITED THERAPEUTICS (UTHR) Change in Receivables: 2009-2024

Historic Change in Receivables for UNITED THERAPEUTICS (UTHR) over the last 16 years, with Dec 2024 value amounting to $400,000.

  • UNITED THERAPEUTICS's Change in Receivables fell 259.69% to -$81.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$44.1 million, marking a year-over-year decrease of 153.00%. This contributed to the annual value of $400,000 for FY2024, which is 99.32% down from last year.
  • UNITED THERAPEUTICS's Change in Receivables amounted to $400,000 in FY2024, which was down 99.32% from $58.5 million recorded in FY2023.
  • In the past 5 years, UNITED THERAPEUTICS's Change in Receivables ranged from a high of $58.5 million in FY2023 and a low of $400,000 during FY2024.
  • Moreover, its 3-year median value for Change in Receivables was $21.7 million (2022), whereas its average is $26.9 million.
  • As far as peak fluctuations go, UNITED THERAPEUTICS's Change in Receivables surged by 588.33% in 2021, and later tumbled by 99.32% in 2024.
  • Yearly analysis of 5 years shows UNITED THERAPEUTICS's Change in Receivables stood at $6.0 million in 2020, then soared by 588.33% to $41.3 million in 2021, then crashed by 47.46% to $21.7 million in 2022, then surged by 169.59% to $58.5 million in 2023, then crashed by 99.32% to $400,000 in 2024.